Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinitecan in patients with metastastic gastric or cardial adenocarcinoma (MGA): Final results of study FFCD9803. - Bouche,O.; Raoul,J.L.; Giovanini,M. (Proc ASCO, 2003)